Raymond James Financial
RBOT

Raymond James Financial’s Vicarious Surgical RBOT Stock Holding History

Raymond James Financial’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26
Closed -$196 – 6356
2025
Q2 		$196 Buy
+26
New +$189 ﹤0.01% 6786

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James Financial's RBOT Position: Q3 2025 in Review

Raymond James Financial sold out of Vicarious Surgical (RBOT) in Q3 2025, closing a stake of 26 shares — an estimated $196 sold.

Raymond James Financial first reported a position in RBOT in Q2 2025 and held it in 1 quarter. The position peaked at $196 in Q2 2025. 32 funds tracked by Wall St. Rank hold RBOT as of Q3 2025.

  • Raymond James Financial reported no remaining Vicarious Surgical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 26 Vicarious Surgical shares in Q3 2025, an estimated $196.
  • Raymond James Financial first reported a position in Vicarious Surgical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Vicarious Surgical position peaked at $196 in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.